alzheimer

As Prices Rise for Parkinson’s, Alzheimer’s Meds, Patients Go Without

This post was originally published on this siteBy Dennis Thompson HealthDay Reporter. WEDNESDAY, Feb. 19, 2020 (HealthDay News) — Rising drug costs are hampering the care of patients with

Read More

Alzheimer’s Association to host educational talks in Belgrade

This post was originally published on this siteBELGRADE- The Alzheimer’s Association is partnering with the Belgrade Community Library to provide educational information about

Read More

Alzheimer’s Disease and Dementia Education Week aims to raise awareness of the prevalent illness

This post was originally published on this siteBENTONVILLE, Ark. (KNWA) — Almost six million Americans are living with Alzheimer’s disease, according to the Alzheimer’s

Read More

Shasta County has the highest death rate of Alzheimer’s in the state

This post was originally published on this siteRedding, Calif. — California is home to 670,000 people living with Alzheimer’s, according to a press release from the Alzheimer’s

Read More

Build-up of brain proteins affects genes in Alzheimer’s disease

This post was originally published on this siteNew research has shed fresh light on how the build-up of two proteins in the brain might affect the activity of genes involved in Alzheimer’s

Read More

Lilly Reports Disappointing Data on Alzheimer’s Candidate

This post was originally published on this siteEli Lilly and Company LLY announced failure to meet endpoint in a phase II/III study on pipeline candidate, solanezumab, in patients with a rare

Read More

Big data can help us find the cure for Alzheimer’s

This post was originally published on this siteWe live in an age of data. Our mobile phones track how many steps we take. Our smart speakers listen to what we say. Our sports watches tell us not

Read More

Roche Reports Disappointing Data on Alzheimer’s Disease Drug

This post was originally published on this siteRoche Holdings RHHBY announced disappointing results from a phase II/III study on pipeline candidate, gantenerumab, in patients with a rare

Read More

A Double Failure of Alzheimer’s Drugs

This post was originally published on this siteLilly and Roche reported their latest disappointments in attempting to effectively treat Alzheimer’s by attacking amyloid plaques. Jim Crumly.

Read More

Pharma Giants Slide On Alzheimer’s Failures — Taking Biogen With Them

This post was originally published on this siteShares of Eli Lilly (LLY) and Roche (RHHBY) slipped Monday after the pharmaceutical companies’ experimental Alzheimer’s treatments

Read More